New insights into weight management by orlistat in comparison with cinnamon as a natural lipase inhibitor
- 48 Downloads
Background and objectives
Orlistat which is taken by obese patients may present some therapeutic assistance through its inhibition of lipase activity. Otherwise, a natural lipase inhibitor as cinnamon is widely used traditional medicine to decrease cholesterol and body weight. The current study aimed to investigate the weight management of orlistat in comparison with cinnamon through different obesity related targets.
Subjects were divided into: Group 1: subjects received cinnamon capsules for 60 days. Group 2: subjects were received orlistat twice daily for 30 days, then once daily for another 30 days. Blood samples were collected at baseline and after 2 months.
Both orlistat and cinnamon groups showed a significant reduction in BMI, lipid profile, and lipase activity compared with baseline. Orlistat group showed significant elevation (p < 0.001) in glucagon, insulin-degrading enzyme (IDE) and dopamine level concomitant with the decrease of serum glutamate compared with baseline level of the same group and cinnamon group. However, cinnamon reduced serum insulin level and insulin resistance (IR) compared with baseline level of the same group and orlistat group.
Orlistat can be used in weight management not only for its pancreatic lipase inhibition but also, due to its indirect appetite reduction effect through elevated glucagon, IDE and dopamine levels and its inhibitory effect on glutamate neurotransmitter, whereas, cinnamon improves BMI and glycaemic targets.
KeywordsCinnamon Dopamine Dyslipidemia Glutamate Obesity Orlistat
Authors thank medical staff members of Diabetes and Endocrinology Unit, Internal Medicine Department, Tanta University Hospital, Egypt, for their help in collecting patient’s data and samples for analysis.
The research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors funded the research.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 5.D. Matsuura, K. Shikano, T. Saito, E. Iwakoshi-Ukena, M. Furumitsu, Y. Ochi, M. Sato, G.E. Bentley, L.J. Kriegsfeld, K. Ukena, Neurosecretory protein GL, a hypothalamic small secretory protein, participates in energy homeostasis in male mice. Endocrinology 158(5), 1120–1129 (2017)CrossRefGoogle Scholar
- 13.S. Genuth, K.G. Alberti, P. Bennett, J. Buse, R. Defronzo, R. Kahn, J. Kitzmiller, W.C. Knowler, H. Lebovitz, A. Lernmark, D. Nathan, J. Palmer, R. Rizza, C. Saudek, J. Shaw, M. Steffes, M. Stern, J. Tuomilehto, P. Zimmet; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 26(11), 3160–3167 (2003)CrossRefGoogle Scholar
- 18.M. Kullin, Z. Li, J. Bondo Hansen, N. Welsh, F.A. Karlsson, S. Sandler, Protection of rat pancreatic islets by potassium channel openers against alloxan, sodium nitroprussideand interleukin- 1beta mediated suppression–possible involvement of themitochondrial membrane potential. Diabetologia 46, 80–88 (2003)CrossRefGoogle Scholar
- 20.S. Landau, A handbook of statistical analyses using SPSS, CRC (2004)Google Scholar
- 21.Organization WH, World Health Organization obesity and overweight fact sheet (2016)Google Scholar
- 22.N.V. Dhurandhar, D. Schoeller, A.W. Brown, S.B. Heymsfield, D. Thomas, T.I. Sørensen, J.R. Speakman, M. Jeansonne, D.B. Allison; Energy Balance Measurement Working Group, Energy balance measurement: when something is not better than nothing. Int J. Obes. (Lond.) 39(7), 1109–1113 (2015)CrossRefGoogle Scholar
- 23.N. Jaradat, A.N. Zaid, F. Hussein, M. Zaqzouq, H. Aljammal, O. Ayesh, Anti-lipase potential of the organic and aqueous extracts of ten traditional edible and medicinal plants in palestine; a comparison study with orlistat. Medicine. 4(4), 89 (2017)Google Scholar
- 24.J.M. Milesn, L. Leiter, P. Hollander, T. Wadden, J.W. Anderson, M. Doyle, J. Foreyt, L. Aronne, S. Klein, Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. Diabetes Care. 25(7), 1123–1128 (2002). https://doi.org/10.2337/diacare.25.7.1123 CrossRefGoogle Scholar
- 25.C.E. McCrea, S.G. West, P.M. Kris-Etherton, J.D. Lambert, T.L. Gaugler, D.L. Teeter, K.A. Sauder, Y. Gu, S.L. Glisan, A.C. Skulas-Ray, Effects of culinary spices and psychological stress on postprandial lipemia and lipase activity: results of a randomized crossover study and in vitro experiments. J. Transl. Med 13, 7 (2015)CrossRefGoogle Scholar
- 26.S.M. Mousavi, J. Rahmani, H. Kord-Varkaneh, A. Sheikhi, B. Larijani, A. Esmaillzadeh, Cinnamon supplementation positively affects obesity: a systematic review and dose-response meta-analysis of randomized controlled trials. Clin. Nutr. pii:S0261-5614(19)30071-8 (2019). https://doi.org/10.1016/j.clnu.2019.02.017. [Epub ahead of print]
- 30.V. Salem, C. Izzi-Engbeaya, C. Coello, D.B. Thomas, E.S. Chambers, A.N. Comninos, A. Buckley, Z. Win, A. Al-Nahhas, E.A. Rabiner, R.N. Gunn, H. Budge, M.E. Symonds, S.R. Bloom, T.M. Tan, W.S. Dhillo, Glucagon increases energy expenditure independently of brown adipose tissue activation in humans. Diabetes Obes. Metab. 18(1), 72–81 (2016)CrossRefGoogle Scholar
- 35.K. Conde, C. Fabelo, W.C. Krause, R. Propst, J. Goethel, D. Fischer, J. Hur, C. Meza, H.A. Ingraham, E.J. Wagner, Testosterone rapidly augments retrograde endocannabinoid signaling in proopiomelanocortin neurons to suppress glutamatergic input from steroidogenic factor 1 neurons via upregulation of diacylglycerol lipase-α. Neuroendocrinology 105(4), 341–356 (2017)CrossRefGoogle Scholar
- 38.C.C. Tsai, I.M. Liu, J.T. Cheng, Stimulatory effect of trans-cinnamaldehyde on norepinephrine secretion in cultured pheochromocytoma (PC-12) cells. Acta Pharm. Sin. 21(12), 1174–1178 (2000)Google Scholar